{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T19:14:30Z","timestamp":1773342870486,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.ejpn.2007.03.010","type":"journal-article","created":{"date-parts":[[2007,7,11]],"date-time":"2007-07-11T11:27:44Z","timestamp":1184153264000},"page":"331-336","source":"Crossref","is-referenced-by-count":43,"title":["Current role of vigabatrin in infantile spasms"],"prefix":"10.1016","volume":"11","author":[{"given":"Pasquale","family":"Parisi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Bombardieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Curatolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2007.03.010_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/01.wco.0000162847.91531.9c","article-title":"The latest of infantile spasms","volume":"18","author":"Riikonen","year":"2005","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.ejpn.2007.03.010_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0074-7742(02)49007-1","article-title":"Histopathology of brain tissue from patients with infantile spasms","volume":"49","author":"Vinters","year":"2002","journal-title":"Int Rev Neurobiol"},{"issue":"1","key":"10.1016\/j.ejpn.2007.03.010_bib3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/01.WNP.0000149893.12678.44","article-title":"Phatogenesis of infantile spasms: a model based on developmental desynchronization","volume":"22","author":"Frost JD & Hrachovy","year":"2005","journal-title":"J Clin Neurophysiol"},{"issue":"11","key":"10.1016\/j.ejpn.2007.03.010_bib4","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S1474-4422(05)70199-X","article-title":"United Kingdom Infantile Spasms Study. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial","volume":"4","author":"Lux","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ejpn.2007.03.010_bib5","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0140-6736(90)90660-W","article-title":"Vigabatrin in infantile spasms","volume":"10","author":"Chiron","year":"1990","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ejpn.2007.03.010_bib6","first-page":"95","article-title":"Vigabatrin and GABA concentration inter-relationship in rat extracellular fluid (EDF) from frontal cortex and hippocampus","volume":"41","author":"Tong","year":"2000","journal-title":"Epilepsia"},{"issue":"7075","key":"10.1016\/j.ejpn.2007.03.010_bib7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/bmj.314.7075.180","article-title":"Severe persistent visual field constriction associated with vigabatrin","volume":"314","author":"Eke","year":"1997","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.ejpn.2007.03.010_bib8","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2165\/00002018-200124110-00003","article-title":"A risk-benefit assessment of treatments for infantile spasms","volume":"24","author":"Nabbout","year":"2001","journal-title":"Drug Saf"},{"issue":"6","key":"10.1016\/j.ejpn.2007.03.010_bib9","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1528-1167.2005.52604.x","article-title":"Vigabatrin in low doses selectively suppresses the clonic component of audiogenically kindled seizures in rats","volume":"46","author":"Vinogradova","year":"2005","journal-title":"Epilepsia"},{"issue":"6\u20137","key":"10.1016\/j.ejpn.2007.03.010_bib10","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.neuint.2005.12.024","article-title":"Acute regulation of steady-state GABA levels following GABA-transaminase inhibition in rat cerebral cortex","volume":"48","author":"de Graaf","year":"2006","journal-title":"Neurochem Int"},{"issue":"8","key":"10.1016\/j.ejpn.2007.03.010_bib11","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s00415-002-0789-y","article-title":"Is visual field constriction in epilepsy patients treated with vigabatrin reversible?","volume":"249","author":"Schmidt","year":"2002","journal-title":"J Neurol"},{"issue":"7","key":"10.1016\/j.ejpn.2007.03.010_bib12","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00415-004-0443-y","article-title":"Are vigabatrin-associated visual field constrictions asymptomatic?","volume":"251","author":"Schmidt","year":"2004","journal-title":"J Neurol"},{"issue":"2","key":"10.1016\/j.ejpn.2007.03.010_bib13","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1177\/0883073891006002101","article-title":"Therapeutic trial of Vigabatrin in refractory infantile spasms","volume":"6","author":"Chiron","year":"1991","journal-title":"J Child Neurol"},{"key":"10.1016\/j.ejpn.2007.03.010_bib14","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1055\/s-2008-1071546","article-title":"Vigabatrin in the treatment of infantile spasms","volume":"24","author":"Vles","year":"1993","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ejpn.2007.03.010_bib15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1055\/s-2008-1071585","article-title":"Vigabatrin in newly diagnosed infantile spasms, letter","volume":"25","author":"Schmitt","year":"1994","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ejpn.2007.03.010_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1059-1311(05)80077-9","article-title":"Vigabatrin in the management of generalized seizures in children","volume":"4","author":"Appleton","year":"1995","journal-title":"Seizure"},{"issue":"7","key":"10.1016\/j.ejpn.2007.03.010_bib17","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1528-1157.1996.tb00627.x","article-title":"Vigabatrin as initial therapy for infantile spasms: a European retrospective survey. Sabril IS Investigator and Peer Review Groups","volume":"37","author":"Aicardi","year":"1996","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.ejpn.2007.03.010_bib18","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/j.1528-1157.1997.tb00063.x","article-title":"Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study","volume":"38","author":"Vigevano","year":"1997","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.ejpn.2007.03.010_bib19","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1111\/j.1528-1157.1999.tb02049.x","article-title":"Randomised, placebo-controlled study of vigabatrin as first line treatment of infantile spasms","volume":"40","author":"Appleton","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2007.03.010_bib20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0887-8994(02)00400-9","article-title":"Vigabatrin for infantile spasms","volume":"27","author":"Mitchell","year":"2002","journal-title":"Pediatr Neurol"},{"issue":"9447","key":"10.1016\/j.ejpn.2007.03.010_bib21","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(04)17400-X","article-title":"The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisone or tetracosactide at 14 days: a multicentre, randomised controlled trial","volume":"364","author":"Lux","year":"2004","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ejpn.2007.03.010_bib22","first-page":"167","article-title":"Efficacy of Vigabatrin in subject with infantile spasms","volume":"46","author":"Elterman","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2007.03.010_bib23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/088307389901400201","article-title":"Vigabatrin in the treatment of infantile spasm in tuberous sclerosis: literature review","volume":"14","author":"Hancock","year":"1999","journal-title":"J Child Neurol"},{"issue":"1","key":"10.1016\/j.ejpn.2007.03.010_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/ejpn.2001.0538","article-title":"Tuberous sclerosis complex: a review of neurological aspects","volume":"6","author":"Curatolo","year":"2002","journal-title":"Eur J Paediatr Neurol"},{"issue":"2","key":"10.1016\/j.ejpn.2007.03.010_bib25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/01.wco.0000218225.50807.12","article-title":"Current management for epilepsy in tuberous sclerosis complex","volume":"19","author":"Curatolo","year":"2006","journal-title":"Curr Opin Neurol"},{"issue":"1\u20132","key":"10.1016\/j.ejpn.2007.03.010_bib26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0920-1211(02)00102-X","article-title":"Characteristics of epilepsy in focal cortical dysplasia in infancy","volume":"51","author":"Lortie","year":"2002","journal-title":"Epilepsy Res"},{"issue":"12","key":"10.1016\/j.ejpn.2007.03.010_bib27","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/j.1528-1167.2005.00339.x","article-title":"Taylor-type focal cortical dysplasia in infants: some MRI lesions almost disappear with maturation of myelination","volume":"46","author":"Eltze","year":"2005","journal-title":"Epilepsia"},{"issue":"42","key":"10.1016\/j.ejpn.2007.03.010_bib28","doi-asserted-by":"crossref","first-page":"9649","DOI":"10.1523\/JNEUROSCI.2687-05.2005","article-title":"Dysfunction of synaptic inhibition in epilepsy associated with focal cortical dysplasia","volume":"25","author":"Calcagnotto","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.ejpn.2007.03.010_bib29","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1093\/brain\/awf175","article-title":"Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome","volume":"125","author":"Tassi","year":"2002","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.ejpn.2007.03.010_bib30","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1046\/j.1528-1157.2001.13501.x","article-title":"Infantile spasms in Down Syndrome: good response to a short course of Vigabatrin","volume":"42","author":"Nabbout","year":"2001","journal-title":"Epilepsia"},{"issue":"s4","key":"10.1016\/j.ejpn.2007.03.010_bib31","first-page":"179","article-title":"Vigabatrin effective in multiple etiologies of infantile spasms","volume":"47","author":"Elterman","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2007.03.010_bib32","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1002\/ana.10626","article-title":"Vigabatrin and newer interventions in succinic semialdehyde dehydrogenase deficiency","volume":"54","author":"Gropman","year":"2003","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.ejpn.2007.03.010_bib33","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejpn.2004.06.004","article-title":"Succinic semialdehyde dehydrogenase deficiency (SSADH) (4-hydroxybutyric aciduria, gamma-hydroxybutyric aciduria)","volume":"8","author":"Gordon","year":"2004","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.ejpn.2007.03.010_bib34","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/08830738060210011801","article-title":"Vigabatrin caused rapidly progressive deterioration in two cases with early myoclonic encephalopathy associated with nonketotic hyperglycinemia","volume":"21","author":"Tekgul","year":"2006","journal-title":"J Child Neurol"},{"issue":"8","key":"10.1016\/j.ejpn.2007.03.010_bib35","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1046\/j.1528-1157.2003.55402.x","article-title":"Short-term nonhormonal and nonsteroid treatment in West sindrome","volume":"44","author":"Capovilla","year":"2003","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.ejpn.2007.03.010_bib36","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1111\/j.0013-9580.2003.29203.x","article-title":"Infantile spasms in remission may reemerge as intractable epileptic spasms","volume":"44","author":"Camfield","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2007.03.010_bib37","first-page":"111","article-title":"Acute psychotic disorder associated with Vigabatrin","volume":"13","author":"Xavier","year":"2000","journal-title":"Acta Med Port"},{"issue":"3","key":"10.1016\/j.ejpn.2007.03.010_bib38","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1023\/B:DOOP.0000005337.39947.83","article-title":"Examining visual field defects in the paediatric population exposed to Vigabatrin","volume":"107","author":"Spencer","year":"2003","journal-title":"Doc Ophthalmol"},{"issue":"2","key":"10.1016\/j.ejpn.2007.03.010_bib39","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1023\/A:1026237730283","article-title":"Visual field defects in pediatric patients on vigabatrin monotherapy","volume":"107","author":"Ascaso","year":"2003","journal-title":"Doc Ophthalmol"},{"issue":"7","key":"10.1016\/j.ejpn.2007.03.010_bib40","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1046\/j.1528-1157.2002.17801.x","article-title":"Visual field constriction in 91 Finnish children treated with vigabatrin","volume":"43","author":"Vanhatalo","year":"2002","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.ejpn.2007.03.010_bib41","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/1531-8249(200007)48:1<60::AID-ANA9>3.0.CO;2-E","article-title":"Visual impairment in children with epilepsy treated with vigabatrin","volume":"48","author":"Gross-Tsur","year":"2000","journal-title":"Ann Neurol"},{"issue":"10","key":"10.1016\/j.ejpn.2007.03.010_bib42","first-page":"1075","article-title":"Study of visual field and vigabatrin treatment in Children","volume":"24","author":"Pelosse","year":"2001","journal-title":"J Fr Ophthalmol"},{"key":"10.1016\/j.ejpn.2007.03.010_bib43","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/eye.2000.83","article-title":"Vigabatrin-associated visual field defects in children","volume":"14","author":"Russell-Eggitt","year":"2000","journal-title":"Eye"},{"issue":"6","key":"10.1016\/j.ejpn.2007.03.010_bib44","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/jnnp.67.6.716","article-title":"Visual field defects associated with vigabatrin monotherapy in children","volume":"67","author":"Luchetti","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9177","key":"10.1016\/j.ejpn.2007.03.010_bib45","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0140-6736(99)02095-4","article-title":"Reversibility of vigabatrin-induced visual-field defect","volume":"354","author":"Versino","year":"1999","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ejpn.2007.03.010_bib46","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s100720070096","article-title":"Another case of reversibility of visual-field defect induced by vigabatrin monotherapy: is young age a favorable factor?","volume":"21","author":"Giordano","year":"2000","journal-title":"Neurol Sci"},{"issue":"7","key":"10.1016\/j.ejpn.2007.03.010_bib47","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1053\/seiz.2001.0544","article-title":"Reversed visual field constrictions in children after vigabatrin withdrawal-true retinal recovery or improved test performance only?","volume":"10","author":"Vanhatalo","year":"2001","journal-title":"Seizure"},{"issue":"4","key":"10.1016\/j.ejpn.2007.03.010_bib48","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1542\/peds.106.4.838","article-title":"Visual field constriction in children with epilepsy on vigabatrin treatment","volume":"106","author":"Iannetti","year":"2000","journal-title":"Pediatrics"},{"issue":"s4","key":"10.1016\/j.ejpn.2007.03.010_bib49","first-page":"179","article-title":"Visual fields in children treated with vigabatrin in infancy","volume":"47","author":"Gaily","year":"2006","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.ejpn.2007.03.010_bib50","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1111\/j.1528-1157.1999.tb01599.x","article-title":"Characteristics of a unique visual field defect attributed to vigabatrin","volume":"40","author":"Wild","year":"1999","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.ejpn.2007.03.010_bib51","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1034\/j.1600-0420.2003.00125.x","article-title":"Characterization of vigabatrin-associated optic atrophy","volume":"81","author":"Frisen","year":"2003","journal-title":"Acta Ophthalmol Scand"},{"issue":"6","key":"10.1016\/j.ejpn.2007.03.010_bib52","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1136\/jnnp.70.6.787","article-title":"Visual field loss associated with vigabatrin: pathological correlations","volume":"70","author":"Ravindran","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.ejpn.2007.03.010_bib53","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1212\/WNL.50.3.614","article-title":"Vigabatrin-associated retinal cone system dysfunction","volume":"50","author":"Krauss","year":"1998","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ejpn.2007.03.010_bib54","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1600-0420.2003.00184.x","article-title":"Vigabatrin-associated loss of vision: rarebit perimetry illuminates the dose\u2013damage relationship","volume":"82","author":"Frisen","year":"2004","journal-title":"Acta Ophthalmol Scand"},{"issue":"suppl 8","key":"10.1016\/j.ejpn.2007.03.010_bib55","first-page":"160","article-title":"AES and safety of Vigabatrin in subject with infantile spasms","volume":"46","author":"Shields","year":"2005","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.ejpn.2007.03.010_bib56","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1528-1167.2006.00422.x","article-title":"Vigabatrin retinopathy in an Irish cohort: lack of correlation with dose","volume":"47","author":"Kinirons","year":"2005","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.ejpn.2007.03.010_bib57","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/sj.eye.6701405","article-title":"The natural history of Vigabatrin associated visual field defects in patients electing to continue their medication","volume":"19","author":"Best","year":"2005","journal-title":"Eye"},{"issue":"9","key":"10.1016\/j.ejpn.2007.03.010_bib58","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1212\/WNL.53.9.2082","article-title":"Visual dysfunction in patients receiving vigabatrin: clinical and electrophysiologic findings","volume":"53","author":"Miller","year":"1999","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.ejpn.2007.03.010_bib59","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.ophtha.2004.03.036","article-title":"Characteristic retinal atrophy with secondary \u201cinverse\u201d optic atrophy identifies vigabatrin toxicity in children","volume":"111","author":"Buncic","year":"2004","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.ejpn.2007.03.010_bib60","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/j.1528-1157.2000.tb00117.x","article-title":"Electro-oculography, electroretinography, visual evoked potentials, and multifocal electroretinography in patients with vigabatrin attributed visual field constriction","volume":"41","author":"Harding","year":"2000","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.ejpn.2007.03.010_bib61","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1212\/WNL.55.3.347","article-title":"Separating the retinal electrophysiologic effects of vigabatrin: treatment versus field loss","volume":"55","author":"Harding","year":"2000","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.ejpn.2007.03.010_bib62","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1212\/WNL.58.8.1261","article-title":"Field-specific visual-evoked potentials: identifying field defects in vigabatrin-treated children","volume":"23,58","author":"Harding","year":"2002","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ejpn.2007.03.010_bib63","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/B:DOOP.0000036780.96560.74","article-title":"Alterations in electroretinograms and retinal morphology in rabbits treated with vigabatrin","volume":"108","author":"Ponjavic","year":"2004","journal-title":"Doc Ophthalmol"},{"issue":"12","key":"10.1016\/j.ejpn.2007.03.010_bib64","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1212\/01.WNL.0000098938.80082.25","article-title":"Peripheral retinal dysfunction in patients taking vigabatrin","volume":"61","author":"Mc Donagh","year":"2003","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ejpn.2007.03.010_bib65","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.nbd.2003.12.004","article-title":"Scotopic threshold response changes after vigabatrin therapy in a child without visual field defects: a new electroretinographic marker of early damage?","volume":"15","author":"Parisi","year":"2004","journal-title":"Neurobiol Dis"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109037980700075X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109037980700075X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,6]],"date-time":"2019-01-06T05:58:17Z","timestamp":1546754297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109037980700075X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S109037980700075X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2007.03.010","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}